April 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2016. This roundup includes...
2017 May Offer Fewer Choices for Affordable Care Act Enrollees
UnitedHealth's exit from most marketplaces highlights health exchanges' growing pains
Psychotherapy May Ease Chemo-Related Cognitive Dysfunction
Researchers suggest their approach could improve survivors' quality of life
Costs for Orally Administered Cancer Drugs Up Since 2000
Gleevec shows one of the largest price increases
FDA Reconsidering Training for Doctors Prescribing Opioids
Next week, FDA committee of outside experts will meet to review risk-management plans
Percutaneous Needle-Based OCT Differentiates Renal Masses
Significantly lower median µOCT for oncocytoma versus renal cell carcinoma
Wide Variation in Health Care Costs Across the U.S.
Even within a state, there can be large differences in price
Ixazomib Ups Progression-Free Survival in Multiple Myeloma
Up in all prespecified patient groups, including those with high-risk cytogenetic abnormalities
Article Discusses Workplace Violence in Health Care
Workplace violence often underreported; health care sector among industries most subject to violence
Optimally Timed Follow-Up Cuts Readmissions After Cystectomy
Timing, frequency of outpatient care helps identify concerning symptoms following radical cystectomy
